- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05956444
NDT on Fall Risk in Cerebral Palsied Children
July 13, 2023 updated by: Fatih Tekin, Pamukkale University
Effect of Neurodevelopmental Treatment on Fall Risk and Balance in Children With Spastic Cerebral Palsy
Children with spastic cerebral palsy experience falls due to weakness in balance skills and abnormalities in gait parameters.
It is necessary to improve the quality of life of these children by reducing the frequency of falling.
Aim of this study was to investigate the effect of Neurodevelopmental Treatment on the risk of falling and balance and to contribute to the literature on this subject.
Cases were randomized into study and control groups.
At the beginning of the study, the balance skills of all the cases with spastic cerebral palsy were measured with the Pediatric Balance Scale, and the gait parameters and fall risks were measured with the LEGSys Temporospatial Gait Analysis Device.
Then, an 8-week, case-specific, neurodevelopmental therapy program with intensive gait and balance training was applied to the study group in a 45-minute single session, 2 days a week.
The control group received 8 weeks of conventional physiotherapy.
At the end of the treatment process, the evaluations were repeated with the same methods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Denizli, Turkey
- Pamukkale University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Cerebral Palsy diagnosis
- Spastic type
- Gross Motor Function Classification System Level I and II
Exclusion Criteria:
- Tendon release surgery or Botox application in the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment Group
Treated with both the treatment programs determined on the basis of the NDT and conventional physiotherapy.
Programs prepared specifically for each child, in a 45-minute single session, 2 days a week, for 8 weeks in total.
Each child was given a treatment program tailored to their needs.
|
In the treatment program; vestibular and proprioceptive training on the balance board; dynamic balance training in sitting with eyes open and closed, kneeling upright and standing; balance exercises in front of the mirror; standing on one leg with eyes open and closed to increase proprioceptive input; vestibular and proprioceptive training on exercise balls of the appropriate size; balance training on the trampoline; footpad sensory stimulation with different materials; weight-bearing training in sitting, crawling, kneeling and standing positions; functional reaching and throwing-holding exercises in different positions; multitasking pieces of training; gait exercises in various ways and training for climbing and descending stairs appropriate to the child's situation (assisted, unaided, symmetrical, reciprocal) took place.
Classical physiotherapy applications for balance.
|
|
Active Comparator: Control Group
Treated with only the treatment programs determined on the basis of conventional physiotherapy.
|
Classical physiotherapy applications for balance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
LEGSys, Temporospatial Gait Analysis Device
Time Frame: Beginning of the study
|
Determining the patient's risk of falling by performing a kinetic analysis of the gait
|
Beginning of the study
|
|
LEGSys, Temporospatial Gait Analysis Device
Time Frame: 8 weeks
|
Determining the patient's risk of falling by performing a kinetic analysis of the gait
|
8 weeks
|
|
Pediatric Balance Scale (PBS)
Time Frame: Beginning of the study
|
Functional balance was assessed using PBS, which consists of fourteen tasks similar to activities of daily living.
Higher scores indicate better balance.
|
Beginning of the study
|
|
Pediatric Balance Scale (PBS)
Time Frame: 8 weeks
|
Functional balance was assessed using PBS, which consists of fourteen tasks similar to activities of daily living.
Higher scores indicate better balance.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Fatih Tekin, Prof., faculty member
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Actual)
August 1, 2022
Study Completion (Actual)
October 1, 2022
Study Registration Dates
First Submitted
July 6, 2023
First Submitted That Met QC Criteria
July 13, 2023
First Posted (Actual)
July 21, 2023
Study Record Updates
Last Update Posted (Actual)
July 21, 2023
Last Update Submitted That Met QC Criteria
July 13, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FallRisk
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Falling
-
University of NebraskaWithdrawn
-
Centre Hospitalier Emile RouxCompleted
-
Eastern Mediterranean UniversityUnknown
-
Beni-Suef UniversityCompleted
-
University of JaénCompleted
-
Tammy MooreCompleted
-
Instituto Politécnico de LeiriaNot yet recruitingFear of FallingPortugal
-
National Healthcare Group PolyclinicsActive, not recruitingFear of FallingSingapore
-
Dr. Mohammad Auais, PhDCompleted
-
Universidad de CaldasUniversidad de ManizalesUnknown
Clinical Trials on Neurodevelopmental Therapy (NDT)
-
Pamukkale UniversityCompleted
-
Lokman Hekim UniversityCompletedCerebral Palsy, SpasticTurkey (Türkiye)
-
Ziauddin UniversityCompleted
-
Medipol UniversityRecruiting
-
Medipol UniversityCompleted
-
Wroclaw University of Health and Sport SciencesNot yet recruitingSpastic Diplegia Cerebral Palsy | Spastic HemiplegiaPoland
-
University of ThessalyNot yet recruiting
-
Pamukkale UniversityCompletedCerebral Palsy | Video GameTurkey (Türkiye)
-
Kahramanmaras Sutcu Imam UniversityCompletedCerebral Palsy | Upper Extremity Dysfunction | Muscle Strength | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Upper Extremity FunctionsTurkey
-
Marmara UniversityCompleted